The Food and Drug Administration (FDA) is holding their annual patient meeting on Sept. 10 in Washington, D.C. The event will also be webcast. Here is what the FDA says will be discussed:
"The meeting will serve as a forum for FDA’s patient stakeholders and the general public, including health professionals, academia, and industry to learn about regulatory issues related to drug development, analyze where in the process patient input may be most practical and most valuable, and explore practicable approaches to incorporating meaningful patient input that will represent broad patient perspectives in medical product development and regulatory decision-making. Specifically, this meeting will provide information and facilitate a discussion about: drug development and regulatory standards, clinical trial design, new regulatory tools for improving pre-market drug regulation, and industry-FDA-patient collaboration for innovative drug development."
Register for the in-person meeting or webcast